Sterne Agee Reiterates “Underperform” Rating for PAREXEL International Corp. (PRXL)
PAREXEL International Corp. (NASDAQ:PRXL)‘s stock had its “underperform” rating reaffirmed by analysts at Sterne Agee in a research report issued to clients and investors on Monday, American Banking and Market News reports. They currently have a $51.07 price target on the stock, up from their previous price target of $36.00.
Shares of PAREXEL International Corp. (NASDAQ:PRXL) opened at 51.07 on Monday. PAREXEL International Corp. has a 52 week low of $28.45 and a 52 week high of $53.55. The stock has a 50-day moving average of $48.7 and a 200-day moving average of $46.14. The company has a market cap of $2.871 billion and a price-to-earnings ratio of 31.72.
PAREXEL International Corp. (NASDAQ:PRXL) last announced its earnings results on Wednesday, August 7th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.07. The company had revenue of $463.10 million for the quarter, compared to the consensus estimate of $455.23 million. During the same quarter in the prior year, the company posted $0.34 earnings per share. The company’s quarterly revenue was up 1.2% on a year-over-year basis.
A number of other analysts have also recently weighed in on PRXL. Analysts at ISI Group upgraded shares of PAREXEL International Corp. from a “neutral” rating to a “buy” rating in a research note to investors on Friday. They now have a $57.00 price target on the stock, up previously from $52.50. Separately, analysts at Ned Davis Research downgraded shares of PAREXEL International Corp. from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 30th. Finally, analysts at Credit Suisse initiated coverage on shares of PAREXEL International Corp. in a research note to investors on Monday, September 23rd. They set an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $48.45.
PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.